Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PORTOLA-PHARMACEUTICALS-I-13255910/news/Portola-Pharmaceuticals-Receives-FDA-Orphan-Drug-Designation-for-Cerdulatinib-an-Oral-Syk-JAK-Inhib-27316889/?utm_source=whatsapp&utm_medium=social&utm_campaign=share